Progress in Medicinal Chemistry, Volume 51

1st Edition

Hardcover ISBN: 9780123964939
eBook ISBN: 9780444594426
Imprint: Elsevier
Published Date: 1st May 2012
Page Count: 160
195.00 + applicable tax
119.00 + applicable tax
148.00 + applicable tax
195.41 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

  1. Small Molecule Bromodomain Inhibitors: Extending the Druggable Epigenome
  2. Chun-wa Chung

  3. TRPV1 Antagonists: Clinical Setbacks and Prospects for Future Development
  4. Michael E. Kort and Philip R. Kym

  5. Multivalent Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) Molecules for the Treatment of COPD
  6. Adam D. Hughes, Alexander McNamara and Tod Steinfeld

  7. Hematopoietic Prostaglandin D-Synthase Inhibitors

    Sukanthini Thurairatnam

Description

Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.

Key Features

  • Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry

Readership

Chemists, biologists, doctors, pharmacists and anyone interested in the contemporary controversy about drugs, drug firms, and the community


Details

No. of pages:
160
Language:
English
Copyright:
© Elsevier 2012
Published:
Imprint:
Elsevier
eBook ISBN:
9780444594426
Hardcover ISBN:
9780123964939